PAPAVERINE HCL/PHENTOLAMINE/PROSTAGLANDIN — Class II drug recall D-0214-2015
Terminated recall by Oregon Compounding Centers, Inc. dba Creative Compounds, reported 2014-11-12, distributed in OR, WA. Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due
| Recall number | D-0214-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Oregon Compounding Centers, Inc. dba Creative Compounds, Wilsonville, OR, United States |
| Recall initiated | 2014-10-06 |
| Classified | 2014-10-31 |
| Reported by FDA | 2014-11-12 |
| Terminated | 2015-06-30 |
| Distributed | OR, WA |
| Quantity | 5 ml |
| Reason classes | sterility |
Product
PAPAVERINE HCL/PHENTOLAMINE/PROSTAGLANDIN, 27.7mg/0.45mg/45.45mcg, injectable, 1.25 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070
Reason for recall
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0214-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.